|

Mazdutide Clinical Trials

2 actively recruiting trials

No change since May 2026

Also known as: GLP-1R and GCGR dual agonist, IBI362

Pipeline

Phase 3: 1Phase 1/2: 1

Top Sponsors

  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1
  • Shanghai Zhongshan Hospital1

Indications

  • Cancer2
  • Diabetes1
  • Type 2 Diabetes1
  • Mild Cognitive Impairment1
  • Polycystic Ovary Syndrome1

Other2 trials

Efficacy of Mazdutide for Treating PCOS
Phase 1/2
GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.